NCT00000304

Dextroamphetamine as an Adjunct in Cocaine Treatment - 1

Dextroamphetamine as an Adjunct in Cocaine Treatment

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: National Institute on Drug Abuse (NIDA) · NIH
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.

Conditions

• Cocaine-Related Disorders
• Substance-Related Disorders

Interventions

Type	Name	Description
DRUG	Dextroamphetamine	15 mg for first 8 weeks and 30 mg for 2nd 8 weeks
DRUG	D-Amphetamine	30 mg for the first 8 weeks and 60 for the second 8 weeks (16 weeks total)
DRUG	Placebo	Placebo

Timeline

• Start date: 1997-08-01
• Primary completion: 2001-08-01
• Completion: 2001-08-01
• First posted: 1999-09-21
• Last updated: 2017-01-12

Locations

1 site across 1 country: United States